Cyclic pentapeptide displaying somatostatin antagonism and metho

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601125S, A61K 3700, C07C10352

Patent

active

045087113

ABSTRACT:
Novel cyclic pentapeptide somatostatin antagonist and method for increasing the release of growth hormone, insulin, and glucagon in mammals are described.

REFERENCES:
patent: 4146612 (1979-03-01), Veber
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4360516 (1982-11-01), Freidinger et al.
patent: 4374060 (1983-02-01), Nutt

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic pentapeptide displaying somatostatin antagonism and metho does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic pentapeptide displaying somatostatin antagonism and metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic pentapeptide displaying somatostatin antagonism and metho will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1090665

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.